REG - Feedback PLC - Further funding to extend NHS Trust pathways

FeedbackAnnouncement

02/09/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240902:nRSB4163Ca&default-theme=true

RNS Number : 4163C  Feedback PLC  02 September 2024

Feedback plc

 

Feedback awarded further funding to extend NHS Trust pathways

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical
infrastructure specialist, is pleased to announce that it has secured further
funding to extend the delivery of its Community Diagnostic Centre ("CDC")
pathway pilot at the Northern Care Alliance NHS Foundation Trust ("NCA") site
in Oldham.

 

Feedback has successfully supported Oldham CDC's application for further
pathway funding from the 2024-25 NHS England budget, securing a paid contract
extension as outlined in the original pilot announcement, on 21 March 2024.
This further funding is for £69,000 with an initial 50% paid from the NHSE H1
budget to 30 September 2024, with the balance expected from the NHSE H2 budget
to continue the pilot to 31 March 2025. The pilot is focused on
breathlessness, further demonstrating the impact of a pathway approach on CDC
utilisation and wider patient wait times. The data generated will complement
positive findings from past and ongoing pilots, building the business case for
further expansion and funding.

 

The coverage of the NCA's Bleepa® based digital referral system, which is
based on a separate Bleepa® contract with Feedback, has also been
significantly expanded since December 2023, when it supported six specialities
at Oldham and one at Fairfield General Hospital. Its total user number has
increased 68% between June 2023 and June 2024 with over 1,400 users at the
sites now generating over 9,200 patient referrals during this period alone. It
now supports eleven specialties, including Endocrinology and Haematology at
Oldham, and five specialities, including Cardiology and Respiratory at
Fairfield.

 

An independent report
(https://feedbackmedical.com/bleepa/northern-care-alliance-cuts-inpatient-referral-times-by-three-quarters-using-bleepa/)
by Unity Insights published in October 2023 found that the NCA identified a
dramatic reduction in clinical response times after switching to Bleepa® from
paper-based referral systems, after examining 10,000 referrals made between
July 2021 to April 2023. The report estimated that the collective time savings
would be worth £819,000 to the NCA over 5 years and, if adopted across the
whole Greater Manchester Integrated Care Board, could free up £7.7m in
savings over the same period.

 

Tom Oakley, CEO of Feedback plc, said: "We are extremely pleased to announce
the confirmation of the funded second stage of our CDC pilot at Oldham and
remain focussed on delivering further evidence that supports the adoption of a
pathway approach for CDCs, enabled by the Bleepa® platform. We see this as
further validation of the value the NCA and NHSE sees in our service and will
use our findings to support national expansion.

 

"As use of our digital inpatient referral system expands to cover more
specialities, more users and capture more referrals at Oldham and Fairfield,
we are eager to build upon the positive findings from Unity's report and
deliver much needed time savings to the NHS."

 

Anand Iyer, NCA CDC Programme Lead at the Northern Care Alliance said: "We are
thrilled to collaborate with Feedback to deliver a clinically transformative
breathlessness pathway at the Oldham Community Diagnostic Centre. This new
pathway enables patients to undergo multiple diagnostic tests in a single
visit, with the Bleepa® system accelerating clinical response times. As a
result, patients will experience significantly reduced waiting times and
receive faster diagnoses."

 

Georges Ng Man Kwong, Chief Clinical Information Officer (Bury, Rochdale and
Oldham) at the Northern Care Alliance, said: "We are delighted that clinical
engagement and onboarding of additional specialities in response to positive
user feedback has led to ongoing systems optimisation, benefits realisation
and value for patients, staff users, our care organisation and the wider
NHS.'"

 

 

Enquiries:

 

 Feedback plc                                                +44 (0) 20 3997 7634

 Tom Oakley, CEO                                             IR@fbk.com (mailto:IR@fbk.com)

 Anesh Patel, CFO

 Panmure Liberum Limited (NOMAD and Broker)                  +44 (0)20 7886 2500

 Emma Earl/Freddy Crossley/Mark Rogers (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd;                                            Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                                             (mailto:feedbackplc@walbrookpr.com)
 Nick Rome/Joe Walker                                        07748 325 236 or 07407 020 470

 

 

About Feedback

 

Feedback plc liberates the data and knowledge from multiple healthcare IT
systems and delivers better workflow to enable clinicians to communicate,
collaborate and provide the best healthcare for their patients. We connect
care settings with diagnostic and other relevant data to drive better, faster,
safer decision that improve outcomes for patients.

 

By linking different clinical systems together into a seamless view of the
patient, we can streamline patient pathways and deliver a digital health and
diagnostics record across multiple care providers.

 

Bleepa® is our communication and collaboration platform that displays
clinical results at a certified and regulated quality, which enables
multi-disciplinary team working and diagnostic-enhanced advice and guidance.
CareLocker® is our patient-facing platform that gives patients access and
control over their diagnostic and other clinical data.

 

The Company has a number of growth opportunities domestically and
internationally across a range of public and private healthcare markets
including the NHS. Our highly scalable software-as-a-service (SaaS) based
model is expected to provide increasing levels of revenue visibility as the
Company grows its customer base.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBLGDCXXGDGSB